Dossier Transformation for Market Expansion

Dossier-Transformation-for-Market-Expansion-_Case-study
Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe.

In this case study, we break down how we:

 

  • Navigated legacy formats and rebuilt submissions to meet CTD standards
  • Handled multilingual data and inaccessible references efficiently
  • Built a scalable dossier structure that reduces future workload

Download the case study to learn about ensuring smooth regulatory review, minimal queries, and no delays to market entry.

Choosing the Right QPPV Partner for EU and Global Compliance

Choosing the Right QPPV Partner for EU and Global Compliance

Pharmacovigilance outsourcing has become crucial for biotech companies to remain compliant and safeguard patients. When you bring a drug to market in Europe or globally, your Qualified Person for Pharmacovigilance (QPPV) serves as your first line of defense. The right...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information